ARCHIVES

NCI-Approved Group, Center Clinical Trials Listed

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Directory Delayed

January 27, 1984

Patient Accrual Up More Than 20% This Year Despite Lack Of Significant New Money For Group

November 18, 1988

NIH Reauthorization Threatened By Fetal Research Issue

October 5, 1990

Federal Budget Cuts Implemented March 1; HHS Agencies Grapple with Consequences

March 8, 2013

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999